To confirm these results, normal PBMCs were transfected with shRNA targeting TLR3, TLR4, TLR8 and TLR9, and then stimulated with the NSCLC plasma collected before chemotherapy. The gene discussed is TLR8; the disease is non-small cell lung carcinoma.